Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Pharmazie in Unserer Zeit
|
March 26, 1998
[Prodrugs for colon targeting]
C S Leopold
Pharmazie in Unserer Zeit
|
June 13, 2001
[Formulation of HIV protease inhibitors. Pharmaceutical technology and biopharmaceutic aspects of HIV protease inhibitors]
C S Leopold
Pharmaceutica Acta Helvetiae
|
August 26, 1998
How accurate is the determination of the relative bioavailability of transdermal drug formulations from pharmacodynamic response data?
C S Leopold
International Journal of Cosmetic Science
|
May 28, 2008
The effect of cream and ointment bases on the steady state penetration of permeants through intact skin: the reciprocal of the onset time of a pharmacodynamic effect as parameter of response
C S Leopold
The Journal of Pharmacy and Pharmacology
|
October 21, 1999
The maximum pharmacodynamic effect as a response parameter: pharmacokinetic considerations
C S Leopold
Medizinische Klinik (Munich, Germany : 1983)
|
April 9, 1999
["Targeted delivery" in the gastrointestinal tract]
C S Leopold
Drug Development and Industrial Pharmacy
|
March 19, 2005
Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations
A Riedel, C S Leopold
Journal of Drug Targeting
|
January 14, 1999
Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD)
C S Leopold, D Eikeler
Skin Pharmacology and Physiology
|
August 26, 2006
Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents
Y Remane, C S Leopold
International Journal of Pharmaceutics
|
September 21, 2014
Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release
R Wulff, C S Leopold
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Pharmazie in Unserer Zeit
|
March 26, 1998
[Prodrugs for colon targeting]
C S Leopold
Pharmazie in Unserer Zeit
|
June 13, 2001
[Formulation of HIV protease inhibitors. Pharmaceutical technology and biopharmaceutic aspects of HIV protease inhibitors]
C S Leopold
Pharmaceutica Acta Helvetiae
|
August 26, 1998
How accurate is the determination of the relative bioavailability of transdermal drug formulations from pharmacodynamic response data?
C S Leopold
International Journal of Cosmetic Science
|
May 28, 2008
The effect of cream and ointment bases on the steady state penetration of permeants through intact skin: the reciprocal of the onset time of a pharmacodynamic effect as parameter of response
C S Leopold
The Journal of Pharmacy and Pharmacology
|
October 21, 1999
The maximum pharmacodynamic effect as a response parameter: pharmacokinetic considerations
C S Leopold
Medizinische Klinik (Munich, Germany : 1983)
|
April 9, 1999
["Targeted delivery" in the gastrointestinal tract]
C S Leopold
Drug Development and Industrial Pharmacy
|
March 19, 2005
Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations
A Riedel, C S Leopold
Journal of Drug Targeting
|
January 14, 1999
Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD)
C S Leopold, D Eikeler
Skin Pharmacology and Physiology
|
August 26, 2006
Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents
Y Remane, C S Leopold
International Journal of Pharmaceutics
|
September 21, 2014
Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release
R Wulff, C S Leopold
Page
of 4